Sekbio Brand New Journey
Dear business partners and friends, We hope you are doing well!
As your generous support and kindness helped us through the challenging time, Sekbio endeavors to provide better products and services. Therefore a new GMP production line has been established to facilitate our R&D and manufacturing. Sekbio team has also transferred to this new working site on May 5th. We believe this change will benefit our cooperation in the long run.
The detail shows as follow:
Previous address:
B503, Building 1, Phase II, Yinxing Science and Technology Park, Guanlan, Shenzhen, China
New address:
10th floor, Building 3, Nam Tai Inno Park, Guangming District, Shenzhen, China
There will be no change in our product offering or marketing activities. Your contact e-mail address will remain the same, and our team will continue to work closely with you after this change.
We combine to bring the global IVD industry to the next level.
Sekbio: Committed to making diagnostics more accurate
Related Immunoassays
- Cardiac Markers
-
Tumor Marker
-
PGII
-
G17
- CA50
-
CA125
- CA242
-
CA15-3
- CA19-9
- CA72-4
-
Pepsinogens I (PGI)
-
Human Epididymis 4 (HE4)
- Prostate-Specific Antigen (PSA)
- Squamous Cell Carcinoma (SCC)
- Neuron-Specific Enolase (NSE)
- Cytokeratin 19 Fragment (CYFRA21-1)
- Human Progastrin-releasing Peptide (ProGRP Tumor Marker)
- Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA II Tumor Marker)
- Alpha-fetoprotein(AFP)
-
CEA
-
Human Chitinase 3-like 1
-
PGII
- Inflammatory Marker
- Infectious Disease
- Hormones
- Thyroid Function
- Glucose Metabolism
- Bone Marker
- Others
-
Heterophilic Blocking Reagent
- Animal Diagnostics
